In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors

Current protocols for hematopoietic stem/progenitor cell (HSPC) gene therapy, involving the transplantation of ex vivo genetically modified HSPCs are complex and not without risk for the patient. We developed a new approach for in vivo HSPC transduction that does not require myeloablation and transp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Richter, Maximilian, Saydaminova, Kamola, Yumul, Roma, Krishnan, Rohini, Liu, Jing, Nagy, Eniko-Eva, Singh, Manvendra, Izsvák, Zsuzsanna, Cattaneo, Roberto, Uckert, Wolfgang, Palmer, Donna, Ng, Philip, Haworth, Kevin G., Kiem, Hans-Peter, Ehrhardt, Anja, Papayannopoulou, Thalia, Lieber, André
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2016
Assuntos:
Gene Therapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5095755/
https://ncbi.nlm.nih.gov/pubmed/27554082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-04-711580
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados